Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | WD domain, G-beta repeat/PFU (PLAA family ubiquitin binding), putative | 0.0036 | 0.0343 | 0.5 |
Onchocerca volvulus | 0.0025 | 0.0005 | 0.5 | |
Echinococcus multilocularis | intestinal type alkaline phosphatase 1 | 0.0329 | 0.8776 | 0.8775 |
Schistosoma mansoni | thyroid hormone receptor | 0.0151 | 0.3656 | 0.4166 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0151 | 0.3656 | 0.3652 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0127 | 0.2963 | 0.2959 |
Schistosoma mansoni | hypothetical protein | 0.0087 | 0.1808 | 0.206 |
Schistosoma mansoni | cationic amino acid transporter | 0.0025 | 0.0005 | 0.0006 |
Brugia malayi | WD domain containing protein | 0.0036 | 0.0343 | 0.234 |
Echinococcus multilocularis | alkaline phosphatase, intestinal, gene 2 | 0.0329 | 0.8776 | 0.8775 |
Loa Loa (eye worm) | hypothetical protein | 0.0075 | 0.1448 | 1 |
Schistosoma mansoni | dihydropyridine-sensitive l-type calcium channel | 0.0162 | 0.3963 | 0.4516 |
Schistosoma mansoni | cationic amino acid transporter | 0.0025 | 0.0005 | 0.0006 |
Echinococcus multilocularis | alkaline phosphatase | 0.0329 | 0.8776 | 0.8775 |
Schistosoma mansoni | cationic amino acid transporter | 0.0025 | 0.0005 | 0.0006 |
Schistosoma mansoni | cationic amino acid transporter | 0.0025 | 0.0005 | 0.0006 |
Leishmania major | hypothetical protein, conserved | 0.0036 | 0.0343 | 0.5 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0127 | 0.2963 | 0.2959 |
Trypanosoma brucei | WD domain, G-beta repeat/PFU (PLAA family ubiquitin binding), putative | 0.0025 | 0 | 0.5 |
Echinococcus multilocularis | phospholipase A 2 activating protein | 0.0036 | 0.0343 | 0.0338 |
Trypanosoma cruzi | WD domain, G-beta repeat/PFU (PLAA family ubiquitin binding), putative | 0.0036 | 0.0343 | 0.5 |
Echinococcus multilocularis | voltage dependent calcium channel subunit | 0.0371 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0171 | 0.422 | 0.4809 |
Echinococcus multilocularis | intestinal type alkaline phosphatase | 0.0329 | 0.8776 | 0.8775 |
Trichomonas vaginalis | phospholipase A-2-activating protein, putative | 0.0036 | 0.0343 | 1 |
Schistosoma mansoni | alkaline phosphatase | 0.0329 | 0.8776 | 1 |
Echinococcus granulosus | alkaline phosphatase intestinal gene 2 | 0.0329 | 0.8776 | 0.8775 |
Schistosoma mansoni | serine-rich repeat protein | 0.0087 | 0.1808 | 0.206 |
Loa Loa (eye worm) | amino acid permease | 0.0025 | 0.0005 | 0.0037 |
Echinococcus granulosus | intestinal type alkaline phosphatase 1 | 0.0329 | 0.8776 | 0.8775 |
Echinococcus granulosus | alkaline phosphatase | 0.0329 | 0.8776 | 0.8775 |
Schistosoma mansoni | thyroid hormone receptor | 0.0151 | 0.3656 | 0.4166 |
Schistosoma mansoni | hypothetical protein | 0.0052 | 0.08 | 0.0912 |
Loa Loa (eye worm) | amino acid permease | 0.0025 | 0.0005 | 0.0037 |
Plasmodium falciparum | polyubiquitin binding protein, putative | 0.0036 | 0.0343 | 0.5 |
Echinococcus granulosus | phospholipase A 2 activating protein | 0.0036 | 0.0343 | 0.0338 |
Schistosoma mansoni | dihydropyridine-sensitive l-type calcium channel | 0.0082 | 0.1647 | 0.1877 |
Schistosoma mansoni | alkaline phosphatase | 0.0329 | 0.8776 | 1 |
Entamoeba histolytica | amino acid permease, putative | 0.0025 | 0.0005 | 0.5 |
Brugia malayi | Cache domain containing protein | 0.0075 | 0.1448 | 1 |
Echinococcus granulosus | voltage dependent calcium channel subunit | 0.0169 | 0.4162 | 0.4159 |
Echinococcus multilocularis | voltage dependent calcium channel subunit | 0.0169 | 0.4162 | 0.4159 |
Toxoplasma gondii | PUL domain-containing protein | 0.0036 | 0.0343 | 0.5 |
Echinococcus granulosus | intestinal type alkaline phosphatase | 0.0329 | 0.8776 | 0.8775 |
Schistosoma mansoni | hypothetical protein | 0.0127 | 0.2963 | 0.3376 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (binding) | < 10 % | Inhibition of RSK2 (unknown origin) using AKRRRLSSLRA as substrate at 10 uM after 60 mins by fluorescence assay relative to control | ChEMBL. | 23434140 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.